Neuroprotective Role of Astroglia in Parkinson Disease by Reducing Oxidative Stress Through Dopamine-Induced Activation of Pentose-Phosphate Pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective Role of Astroglia in Parkinson Disease by Reducing Oxidative Stress Through Dopamine-Induced Activation of Pentose-Phosphate Pathway
Authors
Keywords
-
Journal
ASN Neuro
Volume 10, Issue -, Pages 175909141877556
Publisher
SAGE Publications
Online
2018-05-17
DOI
10.1177/1759091418775562
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?
- (2016) Haruo Nishijima et al. Frontiers in Neuroscience
- Changes in Neuronal Dopamine Homeostasis following 1-Methyl-4-phenylpyridinium (MPP+) Exposure
- (2015) Se Joon Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits
- (2015) S.T. Masoud et al. NEUROBIOLOGY OF DISEASE
- Glutamate as a neurotransmitter in the healthy brain
- (2014) Y. Zhou et al. JOURNAL OF NEURAL TRANSMISSION
- Striatal Astrocytes Act as a Reservoir for L-DOPA
- (2014) Masato Asanuma et al. PLoS One
- Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
- (2014) Kelly M. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parkinson's disease redefined
- (2013) Ariel Y Deutch LANCET NEUROLOGY
- α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
- (2012) Isabel Lastres-Becker et al. HUMAN MOLECULAR GENETICS
- Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson’s and other dopamine deficiency states
- (2012) George F.G. Allen et al. NEUROCHEMISTRY INTERNATIONAL
- Glia: Initiators and progressors of pathology in Parkinson's disease
- (2011) Glenda M. Halliday et al. MOVEMENT DISORDERS
- Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson’s Disease
- (2011) C. Venkateshappa et al. NEUROCHEMICAL RESEARCH
- Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity
- (2010) Ikuko Miyazaki et al. GLIA
- Neuroprotective effects of zonisamide target astrocyte
- (2009) Masato Asanuma et al. ANNALS OF NEUROLOGY
- The Nrf2–ARE cytoprotective pathway in astrocytes
- (2009) Marcelo R. Vargas et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Glutathione—a review on its role and significance in Parkinson’s disease
- (2009) Heather L. Martin et al. FASEB JOURNAL
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
- (2009) Pei-Chun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nrf2 as a Master Redox Switch in Turning on the Cellular Signaling Involved in the Induction of Cytoprotective Genes by Some Chemopreventive Phytochemicals
- (2008) Young-Joon Surh et al. PLANTA MEDICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation